4//SEC Filing
Mixer Jean K 4
Accession 0001246360-19-000764
CIK 0001333170other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:42 PM ET
Size
13.4 KB
Accession
0001246360-19-000764
Insider Transaction Report
Form 4
Mixer Jean K
Director
Transactions
- Disposition to Issuer
Common Stock
2019-02-21$30.00/sh−16,012$480,360→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2019-02-21−15,854→ 0 totalExercise: $18.32From: 2016-06-26Exp: 2023-05-25→ Common Stock (15,854 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2019-02-21−19,724→ 0 totalExercise: $16.81From: 2015-06-21Exp: 2025-05-20→ Common Stock (19,724 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2019-02-21−15,643→ 0 totalExercise: $22.78From: 2017-06-25Exp: 2024-05-24→ Common Stock (15,643 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2019-02-21−23,394→ 0 totalExercise: $13.16From: 2014-05-22Exp: 2024-05-21→ Common Stock (23,394 underlying)
Footnotes (2)
- [F1]Disposed of under Merger Agreement with Fresenius Medical Care Holdings, Inc. in which all outstanding shares of Issuer's Common Stock were converted into the right to receive $30 per share in cash.
- [F2]This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeother
Related Parties
1- filerCIK 0001561158
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:42 PM ET
- Size
- 13.4 KB